Breaking News Instant updates and real-time market news.

TROV

Changed name to CRDF

$1.39 /

+0.005 (+0.36%)

, ABBV

AbbVie

$85.95 /

-1.1 (-1.26%)

08:22
12/04/19
12/04
08:22
12/04/19
08:22

Trovagene reports data on onvansertib in Acute Myeloid Leukemia

Trovagene (TROV) announced new in-vitro and in-vivo data suggesting that onvansertib may provide a new therapeutic option for patients who develop resistance to frontline treatment with venetoclax. The data show that onvansertib, as a single agent, inhibits tumor growth in venetoclax - Abbvie's (ABV) Venclexta - resistant in-vitro and in-vivo models. Additionally, the data also demonstrate synergy with the combination of onvansertib and venetoclax, providing further support for the ability of onvansertib to rescue patients once they show signs of resistance to venetoclax. Currently, there are no viable treatment options for patients once they develop resistance to venetoclax. Onvansertib may represent a new therapeutic option to treat venetoclax-resistant AML and potentially increase progression-free and overall survival for these patients.

TROV

Changed name to CRDF

$1.39 /

+0.005 (+0.36%)

ABBV

AbbVie

$85.95 /

-1.1 (-1.26%)

  • 07

    Dec

TROV Changed name to CRDF
$1.39 /

+0.005 (+0.36%)

03/01/19 Maxim
Trovagene price target lowered to $8 from $18 at Maxim
01/07/19 Noble Capital
Trovagene initiated with an Outperform at Noble Financial
ABBV AbbVie
$85.95 /

-1.1 (-1.26%)

12/03/19 Piper Sandler
Piper survey shows Rinvoq tracking meaningfully ahead of expectations
11/22/19 Canaccord
Harpoon Therapeutics price target raised to $26 from $22 at Canaccord
11/21/19 Roth Capital
Roth says expanded pact a strong sign of AbbVie confidence in Harpoon platform
11/21/19 H.C. Wainwright
Harpoon two-part deal with AbbVie 'early, but impressive,' says H.C. Wainwright

TODAY'S FREE FLY STORIES

Options
Lithium Americas call volume above normal and directionally bullish » 12:05
11/27/20
11/27
12:05
11/27/20
12:05
LAC

Lithium Americas

$11.71 /

+0.65 (+5.88%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LAC Lithium Americas
$11.71 /

+0.65 (+5.88%)

LAC Lithium Americas
$11.71 /

+0.65 (+5.88%)

10/21/20 Roth Capital
Lithium Americas downgraded to Neutral from Buy at Roth Capital
10/20/20 BMO Capital
Lithium Americas price target raised to C$10 from C$8 at BMO Capital
09/23/20 BMO Capital
BMO thinks Tesla project rights not related to Lithium Americas
06/25/20 BMO Capital
Lithium Americas price target raised to C$5 from C$4.40 at BMO Capital
LAC Lithium Americas
$11.71 /

+0.65 (+5.88%)

LAC Lithium Americas
$11.71 /

+0.65 (+5.88%)

LAC Lithium Americas
$11.71 /

+0.65 (+5.88%)

Periodicals
Volkswagen electric supermini at least three years away, FT reports » 11:59
11/27/20
11/27
11:59
11/27/20
11:59
VWAGY

Volkswagen

$0.00 /

+ (+0.00%)

Volkswagen will not…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

05:07 Today Exane BNP Paribas
Volkswagen downgraded to Neutral from Outperform at Exane BNP Paribas
10/22/20 Morgan Stanley
Volkswagen price target raised to EUR 148 from EUR 135 at Morgan Stanley
10/21/20 Societe Generale
Volkswagen price target raised to EUR 190 from EUR 184 at Societe Generale
10/19/20 Goldman Sachs
Volkswagen price target raised to EUR 179 from EUR 169 at Goldman Sachs
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

Options
BlackBerry call volume above normal and directionally bullish » 11:45
11/27/20
11/27
11:45
11/27/20
11:45
BB

BlackBerry

$6.17 /

+0.255 (+4.31%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BB BlackBerry
$6.17 /

+0.255 (+4.31%)

BB BlackBerry
$6.17 /

+0.255 (+4.31%)

06/25/20 Scotiabank
BlackBerry price target raised to $5 from $4.50 at Scotiabank
06/25/20 Canaccord
BlackBerry improvement anticipated throughout year, says Canaccord
04/01/20 MKM Partners
BlackBerry price target lowered to $4.50 from $7.00 at MKM Partners
04/01/20 TD Securities
BlackBerry downgraded to Hold from Buy at TD Securities
BB BlackBerry
$6.17 /

+0.255 (+4.31%)

BB BlackBerry
$6.17 /

+0.255 (+4.31%)

BB BlackBerry
$6.17 /

+0.255 (+4.31%)

BB BlackBerry
$6.17 /

+0.255 (+4.31%)

Recommendations
Rhythm's Imcivree label 'reads bullish' for possible basket trial, says Stifel » 11:25
11/27/20
11/27
11:25
11/27/20
11:25
RYTM

Rhythm Pharmaceuticals

$29.60 /

+5.49 (+22.77%)

Stifel analyst Derek…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RYTM Rhythm Pharmaceuticals
$29.60 /

+5.49 (+22.77%)

RYTM Rhythm Pharmaceuticals
$29.60 /

+5.49 (+22.77%)

10/26/20 Stifel
Rhythm Pharmaceuticals price target raised to $36 from $31 at Stifel
01/08/20 Goldman Sachs
Rhythm Pharmaceuticals initiated with a Sell at Goldman Sachs
RYTM Rhythm Pharmaceuticals
$29.60 /

+5.49 (+22.77%)

RYTM Rhythm Pharmaceuticals
$29.60 /

+5.49 (+22.77%)

Options
Aphria call volume above normal and directionally bullish » 11:25
11/27/20
11/27
11:25
11/27/20
11:25
APHA

Aphria

$7.56 /

+0.535 (+7.62%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APHA Aphria
$7.56 /

+0.535 (+7.62%)

APHA Aphria
$7.56 /

+0.535 (+7.62%)

11/06/20 CIBC
Aphria price target raised to C$9 from C$8 at CIBC
10/16/20 CIBC
Aphria price target raised to C$8 from C$7.50 at CIBC
10/16/20 Cantor Fitzgerald
Aphria price target lowered to C$11.75 from C$15.50 at Cantor Fitzgerald
10/05/20 Cantor Fitzgerald
Aphria price target raised to C$15.50 from C$12.50 at Cantor Fitzgerald
APHA Aphria
$7.56 /

+0.535 (+7.62%)

APHA Aphria
$7.56 /

+0.535 (+7.62%)

APHA Aphria
$7.56 /

+0.535 (+7.62%)

APHA Aphria
$7.56 /

+0.535 (+7.62%)

Technical Analysis
NASDAQ market internals summary » 11:17
11/27/20
11/27
11:17
11/27/20
11:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 11:16
11/27/20
11/27
11:16
11/27/20
11:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Options
FreightCar America call volume off the rails as shares jump 50% » 11:00
11/27/20
11/27
11:00
11/27/20
11:00
RAIL

FreightCar America

$2.85 /

+0.85 (+42.50%)

FreightCar America call…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAIL FreightCar America
$2.85 /

+0.85 (+42.50%)

RAIL FreightCar America
$2.85 /

+0.85 (+42.50%)

Hot Stocks
Boxlight teases upcoming presentation at ISTE20 in blog post » 10:58
11/27/20
11/27
10:58
11/27/20
10:58
BOXL

Boxlight

$1.42 /

-0.025 (-1.73%)

In a post to its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOXL Boxlight
$1.42 /

-0.025 (-1.73%)

BOXL Boxlight
$1.42 /

-0.025 (-1.73%)

10/05/20 Maxim
Boxlight price target raised to $6 from $4 at Maxim
10/01/20 Alliance Global Partners
Boxlight price target raised to $4 from $2.75 at Alliance Global Partners
08/17/20 Maxim
Boxlight price target raised to $4 from $2 at Maxim
08/14/20 Alliance Global Partners
Boxlight price target raised to $2.75 from $1.75 at Alliance Global Partners
BOXL Boxlight
$1.42 /

-0.025 (-1.73%)

  • 29
    Jul
  • 09
    Jun
BOXL Boxlight
$1.42 /

-0.025 (-1.73%)

Conference/Events
Conduent management to meet virtually with Needham » 10:54
11/27/20
11/27
10:54
11/27/20
10:54
CNDT

Conduent

$4.46 /

-0.015 (-0.34%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNDT Conduent
$4.46 /

-0.015 (-0.34%)

CNDT Conduent
$4.46 /

-0.015 (-0.34%)

04/14/20 JPMorgan
JPMorgan downgrades Conduent to Neutral with turnaround 'stretched' by pandemic
04/13/20 JPMorgan
Conduent downgraded to Neutral from Overweight at JPMorgan
CNDT Conduent
$4.46 /

-0.015 (-0.34%)

CNDT Conduent
$4.46 /

-0.015 (-0.34%)

CNDT Conduent
$4.46 /

-0.015 (-0.34%)

CNDT Conduent
$4.46 /

-0.015 (-0.34%)

Conference/Events
Cerence management to meet virtually with Needham » 10:54
11/27/20
11/27
10:54
11/27/20
10:54
CRNC

Cerence

$91.17 /

+4.5 (+5.19%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRNC Cerence
$91.17 /

+4.5 (+5.19%)

CRNC Cerence
$91.17 /

+4.5 (+5.19%)

11/18/20 Goldman Sachs
Cerence assumed with a Buy from Sell at Goldman Sachs
11/17/20 Needham
Cerence price target raised to $95 from $82 at Needham
11/17/20 Craig-Hallum
Cerence price target raised to $90 from $61 at Craig-Hallum
11/17/20 RBC Capital
Cerence downgraded to Sector Perform from Outperform at RBC Capital
CRNC Cerence
$91.17 /

+4.5 (+5.19%)

CRNC Cerence
$91.17 /

+4.5 (+5.19%)

CRNC Cerence
$91.17 /

+4.5 (+5.19%)

Options
Palantir options lead single stocks with 600k contract first hour » 10:50
11/27/20
11/27
10:50
11/27/20
10:50
PLTR

Palantir

$30.30 /

+1.27 (+4.37%)

Palantir options lead…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLTR Palantir
$30.30 /

+1.27 (+4.37%)

PLTR Palantir
$30.30 /

+1.27 (+4.37%)

11/13/20
Fly Intel: Top five analyst downgrades
11/13/20 Jefferies
Palantir price target raised to $18 from $13 at Jefferies
11/13/20 RBC Capital
Palantir price target raised to $15 from $11 at RBC Capital
11/13/20 Morgan Stanley
Morgan Stanley downgrades Palantir to Equal Weight after spike in share price
PLTR Palantir
$30.30 /

+1.27 (+4.37%)

PLTR Palantir
$30.30 /

+1.27 (+4.37%)

PLTR Palantir
$30.30 /

+1.27 (+4.37%)

PLTR Palantir
$30.30 /

+1.27 (+4.37%)

Options
Sorrento Therapeutics call volume above normal and directionally bullish » 10:45
11/27/20
11/27
10:45
11/27/20
10:45
SRNE

Sorrento Therapeutics

$7.99 /

+1.09 (+15.80%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$7.99 /

+1.09 (+15.80%)

SRNE Sorrento Therapeutics
$7.99 /

+1.09 (+15.80%)

07/31/20 H.C. Wainwright
Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright
07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
05/26/20 Dawson James
Sorrento Therapeutics initiated with a Buy at Dawson James
SRNE Sorrento Therapeutics
$7.99 /

+1.09 (+15.80%)

SRNE Sorrento Therapeutics
$7.99 /

+1.09 (+15.80%)

SRNE Sorrento Therapeutics
$7.99 /

+1.09 (+15.80%)

Hot Stocks
Moderna, Novavax advance as questions on AstraZeneca COVID vaccine arise » 10:41
11/27/20
11/27
10:41
11/27/20
10:41
MRNA

Moderna

$124.79 /

+15.61 (+14.30%)

, NVAX

Novavax

$118.65 /

+16.13 (+15.73%)

, AZN

AstraZeneca

$52.14 /

-0.46 (-0.87%)

Shares of smaller…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$124.79 /

+15.61 (+14.30%)

NVAX Novavax
$118.65 /

+16.13 (+15.73%)

AZN AstraZeneca
$52.14 /

-0.46 (-0.87%)

MRNA Moderna
$124.79 /

+15.61 (+14.30%)

07:39 Today Argus
AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus
11/25/20 Goldman Sachs
Moderna price target raised to $139 from $107 at Goldman Sachs
11/23/20
Fly Intel: Top five analyst initiations
11/23/20 Wells Fargo
Moderna initiated with an Equal Weight at Wells Fargo
NVAX Novavax
$118.65 /

+16.13 (+15.73%)

11/17/20 H.C. Wainwright
Novavax price target lowered to $207 from $290 at H.C. Wainwright
10/30/20 Cantor Fitzgerald
Cantor says Novavax vaccine could be 'best-in-class,' but not 'first-in-class'
10/22/20 B. Riley Securities
Novavax price target lowered to $223 from $257 at B. Riley Securities
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
AZN AstraZeneca
$52.14 /

-0.46 (-0.87%)

07:39 Today Argus
AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus
06:25 Today Citi
Citi opens 'positive catalyst watch' on AstraZeneca after vaccine selloff
11/24/20 Piper Sandler
Astra vaccine results 'de-risking' for Altimmune, says Piper Sandler
11/23/20 Morgan Stanley
AstraZeneca price target raised to 9,400 GBp from 9,000 GBp at Morgan Stanley
MRNA Moderna
$124.79 /

+15.61 (+14.30%)

NVAX Novavax
$118.65 /

+16.13 (+15.73%)

AZN AstraZeneca
$52.14 /

-0.46 (-0.87%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$124.79 /

+15.61 (+14.30%)

NVAX Novavax
$118.65 /

+16.13 (+15.73%)

AZN AstraZeneca
$52.14 /

-0.46 (-0.87%)

MRNA Moderna
$124.79 /

+15.61 (+14.30%)

NVAX Novavax
$118.65 /

+16.13 (+15.73%)

AZN AstraZeneca
$52.14 /

-0.46 (-0.87%)

MRNA Moderna
$124.79 /

+15.61 (+14.30%)

NVAX Novavax
$118.65 /

+16.13 (+15.73%)

AZN AstraZeneca
$52.14 /

-0.46 (-0.87%)

Options
GameStop call volume above normal and directionally bullish » 10:25
11/27/20
11/27
10:25
11/27/20
10:25
GME

GameStop

$16.00 /

+1.25 (+8.47%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GME GameStop
$16.00 /

+1.25 (+8.47%)

GME GameStop
$16.00 /

+1.25 (+8.47%)

10/12/20 Jefferies
Jefferies 'pressing pause' on GameStop, downgrades to Hold
10/12/20 Jefferies
GameStop downgraded to Hold from Buy at Jefferies
10/09/20 Benchmark
GameStop price target raised to $6 from $3 at Benchmark
10/08/20 Jefferies
Microsoft deal net positive to GameStop thesis, says Jefferies
GME GameStop
$16.00 /

+1.25 (+8.47%)

GME GameStop
$16.00 /

+1.25 (+8.47%)

GME GameStop
$16.00 /

+1.25 (+8.47%)

GME GameStop
$16.00 /

+1.25 (+8.47%)

Periodicals
About 115,000 Tesla vehicles probed for suspension issues by NHTSA, Reuters says » 10:24
11/27/20
11/27
10:24
11/27/20
10:24
TSLA

Tesla

$592.95 /

+19.09 (+3.33%)

The U.S. National Highway…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$592.95 /

+19.09 (+3.33%)

TSLA Tesla
$592.95 /

+19.09 (+3.33%)

07:13 Today BofA
BofA positive on long-term share gains for NIO Inc. after hosting calls
11/18/20
Fly Intel: Top five analyst upgrades
11/18/20 Morgan Stanley
Morgan Stanley upgrades Tesla on 'profound model shift' to recurring sales
11/18/20 Morgan Stanley
Tesla upgraded to Overweight from Equal Weight at Morgan Stanley
TSLA Tesla
$592.95 /

+19.09 (+3.33%)

  • 14
    Feb
TSLA Tesla
$592.95 /

+19.09 (+3.33%)

TSLA Tesla
$592.95 /

+19.09 (+3.33%)

TSLA Tesla
$592.95 /

+19.09 (+3.33%)

Conference/Events
Truist leisure/gaming analysts hold an analyst/industry conference call » 10:23
11/27/20
11/27
10:23
11/27/20
10:23
GPN

Global Payments

$197.28 /

+0.12 (+0.06%)

Leisure/Gaming Analysts,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GPN Global Payments
$197.28 /

+0.12 (+0.06%)

GPN Global Payments
$197.28 /

+0.12 (+0.06%)

10/30/20 Truist
Global Payments price target lowered to $200 from $235 at Truist
10/20/20 JPMorgan
Global Payments price target raised to $209 from $200 at JPMorgan
10/08/20 Needham
Green Dot price target raised to $70 from $62 at Needham
10/06/20 Credit Suisse
Fiserv upgraded to Outperform at Credit Suisse on improving mix and valuation
GPN Global Payments
$197.28 /

+0.12 (+0.06%)

GPN Global Payments
$197.28 /

+0.12 (+0.06%)

GPN Global Payments
$197.28 /

+0.12 (+0.06%)

Technical Analysis
NASDAQ market internals summary » 10:17
11/27/20
11/27
10:17
11/27/20
10:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Recommendations
Stifel says license deal 'good' for Biogen, takes some upside off table for Sage » 10:16
11/27/20
11/27
10:16
11/27/20
10:16
BIIB

Biogen

$241.73 /

-0.32 (-0.13%)

, SAGE

Sage Therapeutics

$79.50 /

-3.11 (-3.76%)

Stifel analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$241.73 /

-0.32 (-0.13%)

SAGE Sage Therapeutics
$79.50 /

-3.11 (-3.76%)

BIIB Biogen
$241.73 /

-0.32 (-0.13%)

11/10/20 Truist
Truist raises Biogen price target to $443, views aducanumab approval as 'likely'
11/10/20 DZ Bank
Biogen upgraded to Buy from Hold at DZ Bank
11/09/20 BMO Capital
Biogen price target lowered to $253 from $343 at BMO Capital
11/09/20 SVB Leerink
Biogen price target lowered to $382 from $402 at SVB Leerink
SAGE Sage Therapeutics
$79.50 /

-3.11 (-3.76%)

11/19/20 Oppenheimer
Sage Therapeutics price target raised to $94 from $65 at Oppenheimer
11/16/20
Fly Intel: Top five analyst downgrades
11/16/20 Morgan Stanley
Morgan Stanley downgrades Sage Therapeutics amid 'reasonable' expectations
11/16/20 Morgan Stanley
Sage Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
BIIB Biogen
$241.73 /

-0.32 (-0.13%)

SAGE Sage Therapeutics
$79.50 /

-3.11 (-3.76%)

BIIB Biogen
$241.73 /

-0.32 (-0.13%)

BIIB Biogen
$241.73 /

-0.32 (-0.13%)

SAGE Sage Therapeutics
$79.50 /

-3.11 (-3.76%)

BIIB Biogen
$241.73 /

-0.32 (-0.13%)

BIIB Biogen
$241.73 /

-0.32 (-0.13%)

Technical Analysis
NYSE market internals summary » 10:16
11/27/20
11/27
10:16
11/27/20
10:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Options
Rite Aid put volume heavy and directionally bearish » 10:15
11/27/20
11/27
10:15
11/27/20
10:15
RAD

Rite Aid

$12.57 /

+ (+0.00%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RAD Rite Aid
$12.57 /

+ (+0.00%)

RAD Rite Aid
$12.57 /

+ (+0.00%)

11/17/20 Oppenheimer
Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
11/17/20 Goldman Sachs
Goldman says Amazon news likely to pressure entire pharmacy supply chain
09/25/20 Deutsche Bank
Rite Aid price target lowered to $9 from $18 at Deutsche Bank
09/24/20 Evercore ISI
Rite Aid price target lowered to $4 from $6 at Evercore ISI
RAD Rite Aid
$12.57 /

+ (+0.00%)

RAD Rite Aid
$12.57 /

+ (+0.00%)

RAD Rite Aid
$12.57 /

+ (+0.00%)

RAD Rite Aid
$12.57 /

+ (+0.00%)

Hot Stocks
Palantir falls after Citron announces short position with $20 target » 10:15
11/27/20
11/27
10:15
11/27/20
10:15
PLTR

Palantir

$31.00 /

+1.97 (+6.79%)

Shares of Palantir moved…

Shares of Palantir moved lower after Andrew Left's Citron Research announced a new short position in the name with $20 year-end price target. The stock in morning trading is well off the day's highs but remains up 47c to $29.52. Citron said via Twitter, "What a run the past month for all. But as traders looking for short exposure, $PLTR is no longer a stock but a full casino. Does not take a ball of crystal to know this will fall back to Arda. Shorting with a $20 2020 target."

ShowHide Related Items >><<
PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

11/13/20
Fly Intel: Top five analyst downgrades
11/13/20 Jefferies
Palantir price target raised to $18 from $13 at Jefferies
11/13/20 RBC Capital
Palantir price target raised to $15 from $11 at RBC Capital
11/13/20 Morgan Stanley
Morgan Stanley downgrades Palantir to Equal Weight after spike in share price
PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

Conference/Events
Ambarella participates in a conference call with MKM Partners » 10:14
11/27/20
11/27
10:14
11/27/20
10:14
AMBA

Ambarella

$79.15 /

+3.22 (+4.24%)

Conference call with CFO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$79.15 /

+3.22 (+4.24%)

AMBA Ambarella
$79.15 /

+3.22 (+4.24%)

11/24/20 Needham
Ambarella price target raised to $80 from $63 at Needham
11/24/20 Craig-Hallum
Ambarella price target raised to $90 from $75 at Craig-Hallum
11/24/20 Stifel
Ambarella price target raised to $78 from $66 at Stifel
11/24/20 Morgan Stanley
Ambarella price target raised to $83 from $79 at Morgan Stanley
AMBA Ambarella
$79.15 /

+3.22 (+4.24%)

AMBA Ambarella
$79.15 /

+3.22 (+4.24%)

AMBA Ambarella
$79.15 /

+3.22 (+4.24%)

Periodicals
Citron shorting Palantir, sees $20 stock by end of 2020 » 10:13
11/27/20
11/27
10:13
11/27/20
10:13
PLTR

Palantir

$31.00 /

+1.97 (+6.79%)

Andrew Left Citron…

Andrew Left Citron Research said via Twitter, "What a run the past month for all. But as traders looking for short exposure, $PLTR is no longer a stock but a full casino. Does not take a ball of crystal to know this will fall back to Arda. Shorting with a $20 2020 target."

ShowHide Related Items >><<
PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

11/13/20
Fly Intel: Top five analyst downgrades
11/13/20 Jefferies
Palantir price target raised to $18 from $13 at Jefferies
11/13/20 RBC Capital
Palantir price target raised to $15 from $11 at RBC Capital
11/13/20 Morgan Stanley
Morgan Stanley downgrades Palantir to Equal Weight after spike in share price
PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

Hot Stocks
Indivior falls after Reckitt files GBP 1.07B suit over demerger » 10:12
11/27/20
11/27
10:12
11/27/20
10:12
INVVY

Indivior

$0.00 /

+ (+0.00%)

, RBGLY

Reckitt Benckiser

$0.00 /

+ (+0.00%)

Indivior (INVVY) said it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INVVY Indivior
$0.00 /

+ (+0.00%)

INVVY Indivior
$0.00 /

+ (+0.00%)

07/27/20 Citi
Indivior upgraded to Buy from Neutral at Citi
07/27/20 Jefferies
Indivior upgraded to Buy from Hold at Jefferies
07/27/20 Stifel
Indivior upgraded to Buy from Hold at Stifel
RBGLY Reckitt Benckiser
$0.00 /

+ (+0.00%)

11/19/20 Jefferies
Reckitt Benckiser downgraded to Underperform from Hold at Jefferies
11/11/20 Credit Suisse
Reckitt Benckiser upgraded to Outperform from Neutral at Credit Suisse
11/06/20 RBC Capital
Reckitt Benckiser upgraded to Sector Perform from Underperform at RBC Capital
10/23/20 Berenberg
Reckitt Benckiser price target raised to 9,100 GBp from 9,000 GBp at Berenberg

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.